Blackstone completed the acquisition of Takeda Consumer Healthcare, a wholly-owned subsidiary of Takeda focused on the consumer health care market primarily in Japan, for $2.3bn. "Today’s transaction will provide TCHC with the ownership, resources and strategic focus to continue to thrive and meet the needs of customers, while further sharpening Takeda’s strategic focus and commitment to financial discipline and transforming science into life-changing medicines. We are confident that under Blackstone, TCHC will be well-positioned to continue growing and developing its product offerings in the years to come to address the evolving needs of consumers," Christophe Weber, Takeda President and CEO.